FingerprintDive into the research topics of 'A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia'. Together they form a unique fingerprint.
- Sort by
Todd A. Fehniger, Geoffrey L. Uy, Kathryn Trinkaus, Alissa D. Nelson, Jeffery Demland, Camille N. Abboud, Amanda F. Cashen, Keith E. Stockerl-Goldstein, Peter Westervelt, John F. DiPersio, Ravi Vij
Research output: Contribution to journal › Article › peer-review